Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 35

1.

Caffeine improves text reading and global perception.

Franceschini S, Lulli M, Bertoni S, Gori S, Angrilli A, Mancarella M, Puccio G, Facoetti A.

J Psychopharmacol. 2019 Oct 3:269881119878178. doi: 10.1177/0269881119878178. [Epub ahead of print]

PMID:
31578918
2.

Zeta-crystallin: a moonlighting player in cancer.

Lulli M, Nencioni D, Papucci L, Schiavone N.

Cell Mol Life Sci. 2019 Sep 28. doi: 10.1007/s00018-019-03301-3. [Epub ahead of print] Review.

PMID:
31563996
3.

Differential Responses of Colorectal Cancer Cell Lines to Enterococcus faecalis' Strains Isolated from Healthy Donors and Colorectal Cancer Patients.

De Almeida CV, Lulli M, di Pilato V, Schiavone N, Russo E, Nannini G, Baldi S, Borrelli R, Bartolucci G, Menicatti M, Taddei A, Ringressi MN, Niccolai E, Prisco D, Rossolini GM, Amedei A.

J Clin Med. 2019 Mar 20;8(3). pii: E388. doi: 10.3390/jcm8030388.

4.

The Activity of Kv 11.1 Potassium Channel Modulates F-Actin Organization During Cell Migration of Pancreatic Ductal Adenocarcinoma Cells.

Manoli S, Coppola S, Duranti C, Lulli M, Magni L, Kuppalu N, Nielsen N, Schmidt T, Schwab A, Becchetti A, Arcangeli A.

Cancers (Basel). 2019 Jan 23;11(2). pii: E135. doi: 10.3390/cancers11020135.

5.

Cell-targeted c(AmpRGD)-sunitinib molecular conjugates impair tumor growth of melanoma.

Bianchini F, Portioli E, Ferlenghi F, Vacondio F, Andreucci E, Biagioni A, Ruzzolini J, Peppicelli S, Lulli M, Calorini L, Battistini L, Zanardi F, Sartori A.

Cancer Lett. 2019 Apr 1;446:25-37. doi: 10.1016/j.canlet.2018.12.021. Epub 2019 Jan 11.

PMID:
30639534
6.

Sensitivity to imatinib of KCL22 chronic myeloid leukemia cell survival/growth and stem cell potential under glucose shortage.

Bono S, Dello Sbarba P, Lulli M.

Data Brief. 2018 Sep 19;20:1901-1904. doi: 10.1016/j.dib.2018.09.041. eCollection 2018 Oct.

7.

Human fetal adrenal cells retain age-related stem- and endocrine-differentiation potential in culture.

Poli G, Sarchielli E, Guasti D, Benvenuti S, Ballerini L, Mazzanti B, Armignacco R, Cantini G, Lulli M, Chortis V, Arlt W, Romagnoli P, Vannelli GB, Mannelli M, Luconi M.

FASEB J. 2019 Feb;33(2):2263-2277. doi: 10.1096/fj.201801028RR. Epub 2018 Sep 24.

PMID:
30247985
8.

Gold Nanoparticles Functionalized with RGD-Semipeptides: A Simple yet Highly Effective Targeting System for αV β3 Integrins.

Maggi V, Bianchini F, Portioli E, Peppicelli S, Lulli M, Bani D, Sole RD, Zanardi F, Sartori A, Fiammengo R.

Chemistry. 2018 Aug 14;24(46):12093-12100. doi: 10.1002/chem.201801823. Epub 2018 Jul 16.

PMID:
29923243
9.

Bone marrow-derived mesenchymal stem cells promote invasiveness and transendothelial migration of osteosarcoma cells via a mesenchymal to amoeboid transition.

Pietrovito L, Leo A, Gori V, Lulli M, Parri M, Becherucci V, Piccini L, Bambi F, Taddei ML, Chiarugi P.

Mol Oncol. 2018 May;12(5):659-676. doi: 10.1002/1878-0261.12189. Epub 2018 Mar 31.

10.

Imatinib-mesylate enhances the maintenance of chronic myeloid leukemia stem cell potential in the absence of glucose.

Bono S, Dello Sbarba P, Lulli M.

Stem Cell Res. 2018 Apr;28:33-38. doi: 10.1016/j.scr.2018.01.038. Epub 2018 Jan 31.

11.

Wall fluidization in two acts: from stiff to soft roughness.

Derzsi L, Filippi D, Lulli M, Mistura G, Bernaschi M, Garstecki P, Sbragaglia M, Pierno M.

Soft Matter. 2018 Feb 14;14(7):1088-1093. doi: 10.1039/c7sm02093g.

PMID:
29318253
12.

The Leukemic Stem Cell Niche: Adaptation to "Hypoxia" versus Oncogene Addiction.

Cheloni G, Poteti M, Bono S, Masala E, Mazure NM, Rovida E, Lulli M, Dello Sbarba P.

Stem Cells Int. 2017;2017:4979474. doi: 10.1155/2017/4979474. Epub 2017 Jun 4.

13.

Liquid Crystalline Networks toward Regenerative Medicine and Tissue Repair.

Martella D, Paoli P, Pioner JM, Sacconi L, Coppini R, Santini L, Lulli M, Cerbai E, Wiersma DS, Poggesi C, Ferrantini C, Parmeggiani C.

Small. 2017 Dec;13(46). doi: 10.1002/smll.201702677. Epub 2017 Oct 17.

PMID:
29045016
14.

Nanoparticle-Mediated Delivery of Neuroprotective Substances for the Treatment of Diabetic Retinopathy.

Amato R, Dal Monte M, Lulli M, Raffa V, Casini G.

Curr Neuropharmacol. 2018;16(7):993-1003. doi: 10.2174/1570159X15666170717115654. Review.

15.

In vitro and in vivo inhibition of proangiogenic retinal phenotype by an antisense oligonucleotide downregulating uPAR expression.

Lulli M, Cammalleri M, Granucci I, Witort E, Bono S, Di Gesualdo F, Lupia A, Loffredo R, Casini G, Dal Monte M, Capaccioli S.

Biochem Biophys Res Commun. 2017 Aug 26;490(3):977-983. doi: 10.1016/j.bbrc.2017.06.150. Epub 2017 Jun 27.

PMID:
28666875
16.

Fluidization and wall slip of soft glassy materials by controlled surface roughness.

Derzsi L, Filippi D, Mistura G, Pierno M, Lulli M, Sbragaglia M, Bernaschi M, Garstecki P.

Phys Rev E. 2017 May;95(5-1):052602. doi: 10.1103/PhysRevE.95.052602. Epub 2017 May 4.

PMID:
28618470
17.

CHK2 overexpression and mislocalisation within mitotic structures enhances chromosomal instability and hepatocellular carcinoma progression.

Carloni V, Lulli M, Madiai S, Mello T, Hall A, Luong TV, Pinzani M, Rombouts K, Galli A.

Gut. 2018 Feb;67(2):348-361. doi: 10.1136/gutjnl-2016-313114. Epub 2017 Mar 30.

PMID:
28360097
18.

Different BCR/Abl protein suppression patterns as a converging trait of chronic myeloid leukemia cell adaptation to energy restriction.

Bono S, Lulli M, D'Agostino VG, Di Gesualdo F, Loffredo R, Cipolleschi MG, Provenzani A, Rovida E, Dello Sbarba P.

Oncotarget. 2016 Dec 20;7(51):84810-84825. doi: 10.18632/oncotarget.13319.

19.

Albumin Cys34 adducted by acrolein as a marker of oxidative stress in ischemia-reperfusion injury during hepatectomy.

Witort E, Capaccioli S, Becatti M, Fiorillo C, Batignani G, Pavoni V, Piccini M, Orioli M, Carini M, Aldini G, Lulli M.

Free Radic Res. 2016 Aug;50(8):831-9. doi: 10.1080/10715762.2016.1179736. Epub 2016 May 12.

PMID:
27089934
20.

Out-of-equilibrium finite-size method for critical behavior analyses.

Lulli M, Parisi G, Pelissetto A.

Phys Rev E. 2016 Mar;93(3):032126. doi: 10.1103/PhysRevE.93.032126. Epub 2016 Mar 15.

PMID:
27078311
21.

HDAC1 controls CIP2A transcription in human colorectal cancer cells.

Balliu M, Cellai C, Lulli M, Laurenzana A, Torre E, Vannucchi AM, Paoletti F.

Oncotarget. 2016 May 3;7(18):25862-71. doi: 10.18632/oncotarget.8406.

22.

In vitro study on the safety of near infrared laser therapy in its potential application as postmastectomy lymphedema treatment.

Cialdai F, Landini I, Capaccioli S, Nobili S, Mini E, Lulli M, Monici M.

J Photochem Photobiol B. 2015 Oct;151:285-96. doi: 10.1016/j.jphotobiol.2015.08.003. Epub 2015 Aug 11.

PMID:
26355716
23.

Acetyl-11-keto-β-boswellic acid reduces retinal angiogenesis in a mouse model of oxygen-induced retinopathy.

Lulli M, Cammalleri M, Fornaciari I, Casini G, Dal Monte M.

Exp Eye Res. 2015 Jun;135:67-80. doi: 10.1016/j.exer.2015.04.011. Epub 2015 Apr 23.

PMID:
25913458
24.

A pathophysiological view of the long non-coding RNA world.

Di Gesualdo F, Capaccioli S, Lulli M.

Oncotarget. 2014 Nov 30;5(22):10976-96. Review.

25.

CD63 tetraspanin is a negative driver of epithelial-to-mesenchymal transition in human melanoma cells.

Lupia A, Peppicelli S, Witort E, Bianchini F, Carloni V, Pimpinelli N, Urso C, Borgognoni L, Capaccioli S, Calorini L, Lulli M.

J Invest Dermatol. 2014 Dec;134(12):2947-2956. doi: 10.1038/jid.2014.258. Epub 2014 Jun 18.

26.

Anticancer activity of an antisense oligonucleotide targeting TRADD combined with proteasome inhibitors in chemoresistant hepatocellular carcinoma cells.

Witort E, Lulli M, Carloni V, Capaccioli S.

J Chemother. 2013 Oct;25(5):292-7. doi: 10.1179/1973947813Y.0000000087.

PMID:
24070137
27.

Coenzyme Q10 instilled as eye drops on the cornea reaches the retina and protects retinal layers from apoptosis in a mouse model of kainate-induced retinal damage.

Lulli M, Witort E, Papucci L, Torre E, Schipani C, Bergamini C, Dal Monte M, Capaccioli S.

Invest Ophthalmol Vis Sci. 2012 Dec 17;53(13):8295-302. doi: 10.1167/iovs.12-10374.

PMID:
23154463
28.

Coenzyme Q10 protects retinal cells from apoptosis induced by radiation in vitro and in vivo.

Lulli M, Witort E, Papucci L, Torre E, Schiavone N, Dal Monte M, Capaccioli S.

J Radiat Res. 2012 Sep;53(5):695-703. doi: 10.1093/jrr/rrs025. Epub 2012 Jul 22.

29.

Lipolytic effectiveness of phosphatidylcholine in the treatment of 'buffalo hump' of HIV patients.

Witort EJ, Pattarino J, Romano FM, Dini M, Lulli M, Capaccioli S.

J Plast Reconstr Aesthet Surg. 2011 Jan;64(1):e26-8. doi: 10.1016/j.bjps.2010.08.017. Epub 2010 Sep 16. No abstract available.

PMID:
20846919
30.

zeta-Crystallin is a bcl-2 mRNA binding protein involved in bcl-2 overexpression in T-cell acute lymphocytic leukemia.

Lapucci A, Lulli M, Amedei A, Papucci L, Witort E, Di Gesualdo F, Bertolini F, Brewer G, Nicolin A, Bevilacqua A, Schiavone N, Morello D, Donnini M, Capaccioli S.

FASEB J. 2010 Jun;24(6):1852-65. doi: 10.1096/fj.09-140459. Epub 2010 Jan 26.

31.

Cannabinoid receptor activation induces apoptosis through tumor necrosis factor alpha-mediated ceramide de novo synthesis in colon cancer cells.

Cianchi F, Papucci L, Schiavone N, Lulli M, Magnelli L, Vinci MC, Messerini L, Manera C, Ronconi E, Romagnani P, Donnini M, Perigli G, Trallori G, Tanganelli E, Capaccioli S, Masini E.

Clin Cancer Res. 2008 Dec 1;14(23):7691-700. doi: 10.1158/1078-0432.CCR-08-0799.

32.

Impact of targeting the adenine- and uracil-rich element of bcl-2 mRNA with oligoribonucleotides on apoptosis, cell cycle, and neuronal differentiation in SHSY-5Y cells.

Papucci L, Witort E, Bevilacqua AM, Donnini M, Lulli M, Borchi E, Khabar KS, Tempestini A, Lapucci A, Schiavone N, Nicolin A, Capaccioli S.

Mol Pharmacol. 2008 Feb;73(2):498-508. Epub 2007 Nov 7.

PMID:
17989353
33.

Autologous lipofilling: coenzyme Q10 can rescue adipocytes from stress-induced apoptotic death.

Witort EJ, Pattarino J, Papucci L, Schiavone N, Donnini M, Lapucci A, Lulli M, Lo Russo G, Mori A, Dini M, Capaccioli S.

Plast Reconstr Surg. 2007 Apr 1;119(4):1191-9.

PMID:
17496590
34.

Inhibition of 5-lipoxygenase by MK886 augments the antitumor activity of celecoxib in human colon cancer cells.

Cianchi F, Cortesini C, Magnelli L, Fanti E, Papucci L, Schiavone N, Messerini L, Vannacci A, Capaccioli S, Perna F, Lulli M, Fabbroni V, Perigli G, Bechi P, Masini E.

Mol Cancer Ther. 2006 Nov;5(11):2716-26.

35.

Molecular characterization of established human colon carcinoma cell lines (HCT-8) made resistant to 5-fluorouracil by different selection schedules.

Tempestini A, Caciagli B, Morganti M, Witort E, Nobili S, Papucci L, Schiavone N, Donnini M, Landini I, Lapucci A, Perna F, Lulli M, Mazzei T, Sobrero A, Mini E, Capaccioli S.

Oncol Res. 2005;16(3):143-56.

PMID:
16925115

Supplemental Content

Support Center